The rule designed to increase protection for clinical trial participants was set to go into effect next month, but another delay announced today has pushed this date back an additional six months.
Jefferson Institute for Bioprocessing: Site plan and launch update
from BioPharma-Reporter.com
Mylan awaits US FDA rejection for GSK generic
from in-PharmaTechnologist.com
Cellectis bakes safety switch into CAR-T to stop runaway responses
from BioPharma-Reporter.com
US FDA rejects Valeant’s Duobrii for plaque psoriasis
from in-PharmaTechnologist.com
Technology adoption will take time, but foundational work is the key: CRF Health
Clinical evolution
Changing the finish line: Syneos talks bringing payer, patient voice into drug development
Clinical evolution
European CRO Optimapharm enters US market
Globalization
AI-informed virtual assistant to help solve ‘stubborn problems,’ says Saama
Clinical evolution
